TransMedics Group, Inc. (BIT:1TMDX)

TransMedics Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	3,702	4,169	2,096	2,579	1,984	532
Market Cap Growth	58.69%	98.88%	-18.72%	29.99%	272.55%	-1.54%
Enterprise Value	3,729	4,186	2,275	2,698	1,849	483.84
PE Ratio	22.84	24.98	61.73	-102.51	-50.18	-11.97
Forward PE	42.23	47.40	56.70	-	-	-
PS Ratio	7.18	6.88	4.75	10.67	21.23	17.60
PB Ratio	9.19	8.81	9.17	18.79	10.59	7.85
P/TBV Ratio	9.10	10.42	9.61	18.71	9.74	7.80
P/FCF Ratio	32.54	31.21	-25.90	-15.64	-34.37	-16.44
P/OCF Ratio	22.54	21.62	42.95	-197.94	-43.30	-18.45
EV/Sales Ratio	7.05	6.91	5.15	11.17	19.78	15.99
EV/EBITDA Ratio	30.01	30.83	39.74	-131.28	-66.12	-12.86
EV/EBIT Ratio	39.29	38.55	60.67	-93.91	-58.81	-12.27
EV/FCF Ratio	32.78	31.34	-28.11	-16.36	-32.03	-14.94
Debt / Equity Ratio	1.07	1.07	2.26	3.75	0.35	0.65
Debt / EBITDA Ratio	3.83	3.83	9.05	-25.11	-2.42	-1.16
Debt / FCF Ratio	3.89	3.89	-6.40	-3.13	-1.17	-1.35
Net Debt / Equity Ratio	0.07	0.07	0.80	0.88	-0.71	-0.72
Net Debt / EBITDA Ratio	0.23	0.23	3.17	-5.89	4.78	1.29
Net Debt / FCF Ratio	0.23	0.23	-2.24	-0.73	2.32	1.50
Asset Turnover	0.65	0.65	0.58	0.49	0.45	0.21
Inventory Turnover	5.09	5.09	3.95	2.70	1.59	0.68
Quick Ratio	6.41	6.41	7.25	8.34	9.67	4.23
Current Ratio	7.14	7.14	8.30	9.30	10.66	5.11
Return on Equity (ROE)	54.24%	54.24%	19.39%	-15.42%	-28.39%	-51.49%
Return on Assets (ROA)	2.67%	2.67%	5.01%	-6.20%	-15.23%	-27.46%
Return on Invested Capital (ROIC)	5.44%	5.44%	11.25%	-19.41%	-85.45%	-230.24%
Return on Capital Employed (ROCE)	12.60%	12.60%	5.37%	-6.35%	-17.22%	-31.32%
Earnings Yield	4.38%	4.00%	1.62%	-0.98%	-1.99%	-8.35%
FCF Yield	3.07%	3.20%	-3.86%	-6.39%	-2.91%	-6.08%
Buyback Yield / Dilution	-0.40%	-0.40%	-1.09%	-0.28%	-7.33%	-0.26%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.